Drugs / standard dose, inactivated trivalent influenza vaccine (TIV)
standard dose, inactivated trivalent influenza vaccine (TIV)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT01623232 Comparator | Oct 2012 → Nov 2013 | — | US Department of Veterans Affairs | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | standard dose, inactivated trivalent influenza vaccine (TIV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01623232 ↗ |
| Modality | Vaccine | “licensed, inactivated, standard dose influenza vaccine without adjuvant” NCT01623232 ↗ |
| Route | Intramuscular | “Vaccine will be administered IM in the deltoid muscle.” NCT01623232 ↗ |